Published in Am J Kidney Dis on March 01, 2002
Validation of the Oxford classification of IgA nephropathy in cohorts with different presentations and treatments. Kidney Int (2014) 3.40
Corticosteroids in IgA Nephropathy: A Retrospective Analysis from the VALIGA Study. J Am Soc Nephrol (2015) 1.68
Mechanisms of progression of chronic kidney disease. Pediatr Nephrol (2007) 1.52
Pathologic predictors of renal outcome and therapeutic efficacy in IgA nephropathy: validation of the oxford classification. Clin J Am Soc Nephrol (2011) 1.51
A Multicenter Study of the Predictive Value of Crescents in IgA Nephropathy. J Am Soc Nephrol (2016) 1.50
Effect of tonsillectomy plus steroid pulse therapy on clinical remission of IgA nephropathy: a controlled study. Clin J Am Soc Nephrol (2008) 1.35
Immunopathogenesis of IgAN. Semin Immunopathol (2007) 1.16
Serum levels of galactose-deficient immunoglobulin (Ig) A1 and related immune complex are associated with disease activity of IgA nephropathy. Clin Exp Nephrol (2014) 1.00
Progression and regression in renal vascular and glomerular fibrosis. Int J Exp Pathol (2004) 0.99
Significance of the duration of nephropathy for achieving clinical remission in patients with IgA nephropathy treated by tonsillectomy and steroid pulse therapy. Clin Exp Nephrol (2011) 0.97
Validation of the Oxford classification of IgA nephropathy for pediatric patients from China. BMC Nephrol (2012) 0.97
Treatment of IgA nephropathy and Henoch-Schönlein nephritis. Nat Rev Nephrol (2013) 0.90
Changes in Proteinuria and Side Effects of Corticosteroids Alone or in Combination with Azathioprine at Different Stages of IgA Nephropathy. Clin J Am Soc Nephrol (2016) 0.86
Impact of tonsillectomy combined with steroid pulse therapy on immunoglobulin A nephropathy depending on histological classification: a multicenter study. Clin Exp Nephrol (2015) 0.85
Animal models of regression/progression of kidney disease. Drug Discov Today Dis Models (2014) 0.77
The molecular phenotype of endocapillary proliferation: novel therapeutic targets for IgA nephropathy. PLoS One (2014) 0.76
Clinical outcomes of IgA nephropathy patients with different proportions of crescents. Medicine (Baltimore) (2017) 0.75
Effect of low-dose valsartan on proteinuria in normotensive immunoglobulin A nephropathy with minimal proteinuria: a randomized trial. Korean J Intern Med (2016) 0.75
A case of immunoglobulin A nephropathy treated successfully with tonsillectomy and steroid pulse therapy 20 years after onset. CEN Case Rep (2013) 0.75
A case report: a patient with IgA nephropathy and coeliac disease. Complete clinical remission following gluten-free diet. NDT Plus (2009) 0.75
Renal failure and ACE inhibition: how much is too much? Z Kardiol (2005) 0.75
Cohort study of advanced IgA nephropathy: efficacy and limitations of corticosteroids with tonsillectomy. Nephron Clin Pract (2003) 1.49
Glomerulo-tubular junction stenosis as a factor contributing to glomerular obsolescence in IgA nephropathy. J Pathol (2002) 1.48
A nationwide survey of rapidly progressive glomerulonephritis in Japan: etiology, prognosis and treatment diversity. Clin Exp Nephrol (2009) 1.44
Night-time blood pressure is associated with the development of chronic kidney disease in a general population: the Ohasama Study. J Hypertens (2013) 1.39
Increased risk of cardiovascular events and mortality among non-diabetic chronic kidney disease patients with hypertensive nephropathy: the Gonryo study. Hypertens Res (2011) 1.11
Different clinical outcomes for cardiovascular events and mortality in chronic kidney disease according to underlying renal disease: the Gonryo study. Clin Exp Nephrol (2010) 1.07
Renal pathology of ANCA-related vasculitis: proposal for standardization of pathological diagnosis in Japan. Clin Exp Nephrol (2008) 1.05
Serum levels of galactose-deficient immunoglobulin (Ig) A1 and related immune complex are associated with disease activity of IgA nephropathy. Clin Exp Nephrol (2014) 1.00
Higher brachial-ankle pulse wave velocity is associated with more advanced carotid atherosclerosis in end-stage renal disease. Hypertens Res (2005) 1.00
Clinical effectiveness of steroid pulse therapy combined with tonsillectomy in patients with immunoglobulin A nephropathy presenting glomerular haematuria and minimal proteinuria. Nephrology (Carlton) (2010) 1.00
Pharmacokinetics/pharmacodynamics of acetaminophen analgesia in Japanese patients with chronic pain. Biol Pharm Bull (2007) 0.99
Significance of the duration of nephropathy for achieving clinical remission in patients with IgA nephropathy treated by tonsillectomy and steroid pulse therapy. Clin Exp Nephrol (2011) 0.97
Membrane-anchored CD14 is required for LPS-induced TLR4 endocytosis in TLR4/MD-2/CD14 overexpressing CHO cells. Biochem Biophys Res Commun (2005) 0.93
Effect of allopurinol on cardiovascular incidence among hypertensive nephropathy patients: the Gonryo study. Clin Exp Nephrol (2012) 0.91
Plasma profiling of intact isoflavone metabolites by high-performance liquid chromatography and mass spectrometric identification of flavone glycosides daidzin and genistin in human plasma after administration of kinako. Drug Metab Dispos (2008) 0.91
A multicenter prospective cohort study of tonsillectomy and steroid therapy in Japanese patients with IgA nephropathy: a 5-year report. Contrib Nephrol (2007) 0.86
Increased responsiveness to TLR2 and TLR4 ligands during dimethylsulfoxide-induced neutrophil-like differentiation of HL-60 myeloid leukemia cells. Leuk Res (2007) 0.86
Evolution of expression patterns of two odorant-binding protein genes, Obp57d and Obp57e, in Drosophila. Gene (2010) 0.84
Identification and quantification of daidzein-7-glucuronide-4'-sulfate, genistein-7-glucuronide-4'-sulfate and genistein-4',7-diglucuronide as major metabolites in human plasma after administration of kinako. Anal Bioanal Chem (2010) 0.84
Simultaneous determination of prednisolone, prednisone, cortisol, and cortisone in plasma by GC-MS: estimating unbound prednisolone concentration in patients with nephrotic syndrome during oral prednisolone therapy. J Chromatogr B Analyt Technol Biomed Life Sci (2008) 0.82
Metabolism and disposition of isoflavone conjugated metabolites in humans after ingestion of kinako. Drug Metab Dispos (2011) 0.81
Resolution of nodular glomerular lesions in a patient with light-chain nephropathy. Nephron (2002) 0.81
Dialysis staff encouragement and fluid control adherence in patients on hemodialysis. Nephrol Nurs J (2009) 0.81
High-performance liquid chromatographic determination of quercetin in human plasma and urine utilizing solid-phase extraction and ultraviolet detection. J Chromatogr B Analyt Technol Biomed Life Sci (2003) 0.81
Tonsillectomy combined with steroid pulse therapy: a curative therapy for IgA nephropathy. Acta Otolaryngol Suppl (2004) 0.80
Evaluation of 11beta-HSD activities in vivo following oral administration of cortisol-13C4,2H1 to a human subject. Steroids (2003) 0.80
Resolution of typical lipoprotein glomerulopathy by intensive lipid-lowering therapy. Am J Kidney Dis (2003) 0.80
Use of 11alpha-deuterium labeled cortisol as a tracer for assessing reduced 11beta-HSD2 activity in vivo following glycyrrhetinic acid ingestion in a human subject. Steroids (2005) 0.79
Missense and nonsense mutations of the flavin-containing monooxygenase 3 gene in a Japanese cohort. Drug Metab Pharmacokinet (2007) 0.79
Enhanced expression of C chemokine lymphotactin in IgA nephropathy. Nephron (2002) 0.78
A case of primary aldosteronism associated with renal artery stenosis and preclinical Cushing's syndrome. Hypertens Res (2008) 0.78
Simultaneous determination of androstenedione, 11beta-hydroxyandrostenedione, and testosterone in human plasma by stable isotope dilution mass spectrometry. J Chromatogr B Analyt Technol Biomed Life Sci (2009) 0.77
High incidence of Dieulafoy's lesions in upper gastrointestinal bleeding associated with polyarteritis--clinical examination of patients of polyarteritis nodosa with rapidly progressive glomerulonephritis. Hepatogastroenterology (2008) 0.77
Predictive factors of clinical outcome in patients with diffuse proliferative lupus nephritis treated early by intravenous methylprednisolone pulse therapy. Ren Fail (2007) 0.76
Decreased CD4 lymphocyte count as a marker predicting high mortality rate in managing ANCA related rapidly progressive glomerulonephritis. Nephron (2002) 0.76
[Muscular sarcoidosis associated with acute renal failure due to hypercalcemia]. Nihon Naika Gakkai Zasshi (2003) 0.76
Simultaneous determination of glucuronic acid and sulfuric acid conjugated metabolites of daidzein and genistein in human plasma by high-performance liquid chromatography. J Chromatogr B Analyt Technol Biomed Life Sci (2010) 0.75
Intraindividual and interindividual variabilities in endogenous cortisol 6β-hydroxylation clearance as an index for in vivo CYP3A phenotyping in humans. Drug Metab Dispos (2012) 0.75
Anti-VEGF therapy for crescentic glomerulonephritis? Am J Kidney Dis (2008) 0.75
Survey of the effects of a column for adsorption of β2-microglobulin in patients with dialysis-related amyloidosis in Japan. Ther Apher Dial (2012) 0.75
Separation and quantitative determination of 6α-hydroxycortisol and 6β-hydroxycortisol in human urine by high-performance liquid chromatography with ultraviolet absorption detection. Anal Bioanal Chem (2012) 0.75
Distinct Distribution of Immunocytes in a Retropharyngeal Lymphadenopathy Associated with Kawasaki Disease: A Case Study Compared with Tonsillitis. Cardiology (2017) 0.75
Validation of the plasma half-life of 11alpha-deuterium cortisol as a sensitive index for the analysis of human 11beta-HSD2 activity in vivo. Steroids (2005) 0.75
Measurement of cortisol secretion rate by stable isotope methodology following oral administration of 13C-labeled cortisol to a human subject. Steroids (2002) 0.75
Theory of the optical conductivity of spin liquid states in one-dimensional Mott insulators. Phys Rev Lett (2009) 0.75
Simultaneous determination of endogenous and stable isotope-labelled 6beta-hydroxycortisols in human urine by stable isotope dilution mass spectrometry. J Chromatogr B Analyt Technol Biomed Life Sci (2003) 0.75
Improvements in treatment strategies for patients with antineutrophil cytoplasmic antibody-associated rapidly progressive glomerulonephritis. Ther Apher Dial (2006) 0.75
Predictive value of urinary micro-cholesterol (mCHO) levels in patients with progressive glomerular disease. Kidney Int (2004) 0.75
[Awareness about and educational intervention for chronic kidney disease in the general population: from a survey of participants at the CKD educational lecture in Miyagi prefecture]. Nihon Jinzo Gakkai Shi (2014) 0.75
[Membranoproliferative glomerulonephritis]. Nihon Rinsho (2004) 0.75
Impact of annual urine health check-up system to obtain clinical remission in patients with IgA nephropathy. Contrib Nephrol (2007) 0.75
[Soluble fibrin is not excreted in urine and its plasma level is elevated in nephrotic syndrome]. Rinsho Byori (2009) 0.75
[Clinical significance of urinary cholesterol/total protein ratio as a marker of selectivity of proteinuria: comparison with selectivity index]. Rinsho Byori (2009) 0.75
Correlation between the physicochemical property of some nonsteroidal anti-inflammatory drugs and changes in adenosine triphosphate, glutathione and hemoglobin in rat erythrocytes. Biol Pharm Bull (2003) 0.75